Average Insider

Where insiders trade, we follow

SpyGlass Pharma, Inc. Common Stock ($SGP)
Accession: 0001193125-26-046671
Feb 11, 2026
๐Ÿ“ˆ Chart on TradingView๐Ÿ’ฐ Financials on Finviz
52W Low$20.16
Current$29.1373.0% above low, 27.0% below high
52W High$32.44

Filing Information

Accession Number0001193125-26-046671
Form Type4
Filing DateFeb 11, 2026
Document DateFeb 9, 2026
DocumentView SEC Filing
Transactions
9
Total Shares
11,132,576
Total Value
$15,000,000.00
P&L
+82.1% (+$12,309,375.00)

Transactions

NameTitleSecurityDerivativeTransaction DateTypeSharesPriceTotal CostShares AfterDirect/IndirectNature of OwnershipActions
New Enterprise Associates 17, L.P.
10% Owner
Common Stock
โ€”Feb 9, 2026Conversion1,619,240โ€”โ€”1,619,240Directโ€”View Details
New Enterprise Associates 17, L.P.
10% Owner
Common Stock
โ€”Feb 9, 2026Conversion1,370,168โ€”โ€”2,989,408Directโ€”View Details
New Enterprise Associates 17, L.P.
10% Owner
Common Stock
โ€”Feb 9, 2026Conversion1,370,168โ€”โ€”4,359,576Directโ€”View Details
New Enterprise Associates 17, L.P.
10% Owner
Common Stock
โ€”Feb 9, 2026Conversion737,962โ€”โ€”5,097,538Directโ€”View Details
New Enterprise Associates 17, L.P.
10% Owner
Common Stock
โ€”Feb 9, 2026Purchase937,500$16.00$15,000,000.006,035,038Directโ€”View Details
New Enterprise Associates 17, L.P.
10% Owner
Series B Preferred Stock
(Common Stock)
DerivativeFeb 9, 2026Conversion1,619,240โ€”โ€”0Directโ€”View Details
New Enterprise Associates 17, L.P.
10% Owner
Series C-1 Preferred Stock
(Common Stock)
DerivativeFeb 9, 2026Conversion1,370,168โ€”โ€”0Directโ€”View Details
New Enterprise Associates 17, L.P.
10% Owner
Series C-2 Preferred Stock
(Common Stock)
DerivativeFeb 9, 2026Conversion1,370,168โ€”โ€”0Directโ€”View Details
New Enterprise Associates 17, L.P.
10% Owner
Series D Preferred Stock
(Common Stock)
DerivativeFeb 9, 2026Conversion737,962โ€”โ€”0Directโ€”View Details
Version: v26.3.23